SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-060206
Filing Date
2023-11-07
Accepted
2023-11-07 16:01:30
Documents
66
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q idya-20230930.htm   iXBRL 10-Q 3137569
2 EX-31.1 idya-ex31_1.htm EX-31.1 17188
3 EX-31.2 idya-ex31_2.htm EX-31.2 16772
4 EX-32.1 idya-ex32_1.htm EX-32.1 14053
  Complete submission text file 0000950170-23-060206.txt   9407434

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT idya-20230930_def.xml EX-101.DEF 219500
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT idya-20230930_pre.xml EX-101.PRE 348590
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT idya-20230930_cal.xml EX-101.CAL 38312
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT idya-20230930_lab.xml EX-101.LAB 458470
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT idya-20230930.xsd EX-101.SCH 56091
60 EXTRACTED XBRL INSTANCE DOCUMENT idya-20230930_htm.xml XML 1478430
Mailing Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-443-6209
IDEAYA Biosciences, Inc. (Filer) CIK: 0001676725 (see all company filings)

IRS No.: 474268251 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38915 | Film No.: 231383549
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences